A 10-Year Saudi Experience of Using Adalimumab in Treating Juvenile Idiopathic Arthritis

Journals Menu

Follow SCIRP

ISSN Print: 2163-9914
ISSN Online: 2164-005X
www.scirp.org/journal/ojra
E-mail: ojra@scirp.org

Citations

"A 10-Year Saudi Experience of Using Adalimumab in Treating Juvenile Idiopathic Arthritis"
written by Mohammad A. Muzaffer, Asraa Turkistani, Logain S. Alahmadi, Samaa Sangoof,
published by Open Journal of Rheumatology and Autoimmune Diseases, Vol.9 No.2, 2019

has been cited by the following article(s):

[1]	Efficacy and safety of tumor necrosis factor inhibitors for systemic juvenile idiopathic arthritis: a systematic review
	Modern …, 2024

[2]	Current Review of Systemic Juvenile Idiopathic Arthritis: What Do Paediatricians Need to Know?
	2020

[1]	Efficacy and safety of tumor necrosis factor inhibitors for systemic juvenile idiopathic arthritis: A systematic review Modern Rheumatology, 2024 DOI:10.1093/mr/roae050

[2]	Efficacy and safety of tumor necrosis factor inhibitors for systemic juvenile idiopathic arthritis: A systematic review Modern Rheumatology, 2024 DOI:10.1093/mr/roae050

[3]	Current Review of Systemic Juvenile Idiopathic Arthritis: What Do Paediatricians Need to Know? Open Journal of Pediatrics, 2020 DOI:10.4236/ojped.2020.104078

Follow SCIRP